• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白色念珠菌眼内炎患者中米卡芬净的眼内穿透性。

Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.

机构信息

Department of Ophthalmology, Gifu University Graduate School of Medicine, Gifu, Japan.

出版信息

J Ocul Pharmacol Ther. 2011 Oct;27(5):531-3. doi: 10.1089/jop.2011.0026. Epub 2011 Jul 13.

DOI:10.1089/jop.2011.0026
PMID:21751880
Abstract

PURPOSE

To investigate the penetration of micafungin, a new class of echinocandin antifungal agent, into the aqueous humor and vitreous after an intravenous administration.

METHODS

Endogenous endophthalmitis caused by Candida albicans developed bilaterally in a 67-year-old man. Three hours before vitrectomy, the patient received an intravenous injection of 300 mg micafungin. Samples of aqueous and vitreous were collected during the vitrectomy approximately 60 min after the intravenous injection. The concentration of micafungin in both bodies was determined by high-performance liquid chromatography.

RESULTS

The concentration of micafungin was 25.36 μg/mL in the serum, 0.026 μg/mL in the aqueous, and 0.043 μg/mL in the vitreous. The micafungin minimum inhibitory concentration (MIC) against the C. albicans strain isolated from our patient was 0.03 μg/mL. Thus, the micafungin reached the MIC in the vitreous.

CONCLUSION

We suggest that intravenous micafungin should be considered in mild cases of endogenous fungal endophthalmitis, or be given in combination with other intravitreal antifungal agents with vitrectomy in more severe cases.

摘要

目的

研究新型棘白菌素类抗真菌药物米卡芬净静脉给药后在房水和玻璃体内的渗透情况。

方法

一名 67 岁男性双侧发生白色念珠菌性内源性眼内炎。在玻璃体切除术前 3 小时,患者静脉注射 300mg 米卡芬净。在静脉注射后约 60 分钟进行玻璃体切除手术时采集房水和玻璃体液样本。通过高效液相色谱法测定两种体液中米卡芬净的浓度。

结果

血清中米卡芬净的浓度为 25.36μg/mL,房水中为 0.026μg/mL,玻璃体内为 0.043μg/mL。从我们患者分离出的白色念珠菌菌株对米卡芬净的最小抑菌浓度(MIC)为 0.03μg/mL。因此,玻璃体内达到了米卡芬净的 MIC。

结论

我们建议对于轻度内源性真菌性眼内炎,可以考虑静脉给予米卡芬净,或者在更严重的情况下联合玻璃体腔内其他抗真菌药物并进行玻璃体切除术。

相似文献

1
Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.白色念珠菌眼内炎患者中米卡芬净的眼内穿透性。
J Ocul Pharmacol Ther. 2011 Oct;27(5):531-3. doi: 10.1089/jop.2011.0026. Epub 2011 Jul 13.
2
Intraocular penetration of intravenous micafungin in inflamed human eyes.静脉注射米卡芬净在炎症人眼中的眼内穿透。
Antimicrob Agents Chemother. 2013 Aug;57(8):4027-30. doi: 10.1128/AAC.02300-12. Epub 2013 May 20.
3
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.伏立康唑和卡泊芬净治疗内源性真菌性眼内炎
Am J Ophthalmol. 2005 Jan;139(1):135-40. doi: 10.1016/j.ajo.2004.08.077.
4
Vitreous and aqueous penetration of intravitreally and orally administered moxifloxacin in an experimental rabbit model of fungal endophthalmitis.实验性兔真菌性眼内炎模型中玻璃体内和口服给予莫西沙星的玻璃体液和房水穿透性。
J Pharm Pharmacol. 2013 May;65(5):659-64. doi: 10.1111/jphp.12029. Epub 2013 Jan 25.
5
Management of a case of endogenous endophthalmitis with intravitreal caspofungin.玻璃体腔内注射卡泊芬净治疗1例内源性眼内炎
Indian J Ophthalmol. 2017 Jun;65(6):529-531. doi: 10.4103/ijo.IJO_781_16.
6
[Comparison of different antifungal treatment regimens for experimental Candida endophthalmitis in rabbit models].[兔模型实验性念珠菌性眼内炎不同抗真菌治疗方案的比较]
Mikrobiyol Bul. 2009 Oct;43(4):619-26.
7
Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis.玻璃体内注射两性霉素B脂质体治疗内源性念珠菌性眼内炎。
Jpn J Ophthalmol. 2015 Sep;59(5):346-52. doi: 10.1007/s10384-015-0397-x. Epub 2015 Jul 28.
8
Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis.米卡芬净对热带念珠菌眼内炎的体外数据与临床疗效的差异。
J Infect Chemother. 2012 Oct;18(5):786-9. doi: 10.1007/s10156-012-0370-2. Epub 2012 Jun 29.
9
Intraocular penetration of itraconazole in patient with fungal endophthalmitis.伊曲康唑在真菌性眼内炎患者中的眼内穿透情况。
Int Ophthalmol. 2013 Oct;33(5):579-81. doi: 10.1007/s10792-012-9696-0. Epub 2012 Dec 21.
10
Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.比较莫西沙星、脂质体两性霉素 B 及联合治疗对兔实验性白色念珠菌眼内炎的抗真菌疗效。
Can J Microbiol. 2010 Jan;56(1):1-7. doi: 10.1139/w09-112.

引用本文的文献

1
Antimicrobial guide to posterior segment infections.后段感染的抗菌治疗指南。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2473-2501. doi: 10.1007/s00417-020-04974-4. Epub 2020 Nov 6.
2
Histological Effects of Intravitreal Injection of Antifungal Agents in New Zealand White Rabbits: An Electron Microscopic and Immunohistochemical Study.玻璃体内注射抗真菌药物对新西兰白兔的组织学影响:一项电子显微镜和免疫组织化学研究。
Pharmaceuticals (Basel). 2020 Sep 23;13(10):267. doi: 10.3390/ph13100267.
3
Risk factors and outcomes of patients with ocular involvement of candidemia.
眼念珠菌病患者的风险因素和结局。
PLoS One. 2019 Sep 6;14(9):e0222356. doi: 10.1371/journal.pone.0222356. eCollection 2019.
4
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.米卡芬净的临床药代动力学和药效学。
Clin Pharmacokinet. 2018 Mar;57(3):267-286. doi: 10.1007/s40262-017-0578-5.
5
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.抗真菌药物的药代动力学:优化患者治疗的实际意义。
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
6
Tissue penetration of antifungal agents.抗真菌药物的组织穿透性。
Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.
7
Intraocular penetration of intravenous micafungin in inflamed human eyes.静脉注射米卡芬净在炎症人眼中的眼内穿透。
Antimicrob Agents Chemother. 2013 Aug;57(8):4027-30. doi: 10.1128/AAC.02300-12. Epub 2013 May 20.
8
Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.米卡芬净:在预防和治疗侵袭性念珠菌感染中的应用综述。
Drugs. 2012 Nov 12;72(16):2141-65. doi: 10.2165/11209970-000000000-00000.